A third party reproduction includes any process where a person apart from intended parents desiring to have a child provides sperm, or eggs, or use of a uterus to help someone else to have a child. For several years, a third party reproduction was restricted to using donor sperm.
Using donor sperm increased greatly in the 1960s, and the first commercial donor sperm bank opened up in 1971. However, it was not until the development of In vitro fertilization (IVF) and its resulting growth that the third party reproduction started to draw significant attention. The very first IVF-made birth happened in England in 1978, after many years of work. The first IVF birth in Ukraine happened almost 26 years ago.
While there are too many ethical, mental and legal complexities to donor insemination, the brand new third party reproduction services that resulted from IVF raised many new and much more complex questions. Donor insemination involves for the most third party people – a sperm donor, a woman who was inseminated with his sperm and a woman’s partner or husband, if she is not alone.
You will find no medical risks with donor insemination, and the cost of donor insemination is comparatively low. In comparison, third party reproduction methods resulted from IVF, can involve as much as four people – sperm donor or egg donor, gestational carrier, intended mother and intended father.
As opposed to a sperm donation, surrogates and egg donors are in danger of medical complications. In addition, the cost of using surrogates and egg donors is very high. Thus, it is not surprising that the creation of these more complicated third party reproduction methods has produced a lot of interest and debates.
Fertility treatments have significantly altered the outcome for patients who otherwise would not have a chance to have a child. Solutions and choices have grown progressively, with many advances depending on the accessibility to the patient’s own genetic material. If this is not an option, using egg donation turns into an alternative treatment. The interest for fertility treatments using egg donation has grown tremendously. The procedure by which donors participate resembles the one for IVF and Embryo Transfer (IVF/ET).
There are several important particular procedural variations, however, which are specific to the donor’s and recipient’s cycles, representing an additional challenge for the reproductive endocrinology team. New cryopreservation systems are enabling the development of yet another pool of donor eggs and could increase the possibilities for potential readers. Although the egg donation gives infertile women the chance to get pregnant, it might expose to unforeseen procedural, gestational and long-term risks. Through the years, a number of complaints were made concerning the medical effects for the donor, the mother and the offspring born with egg donation process.